CompletedNot Applicable

Non-contrast 3D MR Angiography for Assessment of the Thoracic Aorta in Pregnancy

United Kingdom15 participantsStarted 2015-01

Plain-language summary

Introduction: Native magnetic resonance angiography (MRA) is recommended to assess the thoracic aorta during pregnancy, avoiding the risks of ionising radiation and contrast agent administration. This guidance is however, based only on consensus opinion supported by limited case reports (level of evidence C). Aim: To evaluate the feasibility of performing native 3D steady-state free-precession (SSFP) MRA in pregnant subjects with inherited aortopathy to guide timing and mode of delivery.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any pregnant subject with a history of familial aortopathy Exclusion Criteria: * None

What they're measuring

Gestation at delivery

Timeframe: 40 weeks

Completion of non-contrast 3D MRA aorta

Timeframe: 40 weeks

Trial details

NCT IDNCT02793570

SponsorUniversity Hospital Birmingham NHS Foundation Trust

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-10

View on ClinicalTrials.gov More Magnetic Resonance Imaging trials